Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Absence of ghrelin protects against early-onset obesity
Katherine E. Wortley, … , Michael O. Thorner, Mark W. Sleeman
Katherine E. Wortley, … , Michael O. Thorner, Mark W. Sleeman
Published December 1, 2005
Citation Information: J Clin Invest. 2005;115(12):3573-3578. https://doi.org/10.1172/JCI26003.
View: Text | PDF
Research Article Metabolism

Absence of ghrelin protects against early-onset obesity

  • Text
  • PDF
Abstract

The gut peptide ghrelin, the endogenous ligand for the growth hormone secretagogue receptor, has been implicated not only in the regulation of pituitary growth hormone (GH) secretion but in a number of endocrine and nonendocrine functions, including appetitive behavior and carbohydrate substrate utilization. Nevertheless, recent genetic studies have failed to show any significant defects in GH levels, food intake, or body weight in adult ghrelin-deficient (Ghrl−/−) mice. Here we demonstrate that male Ghrl−/− mice are protected from the rapid weight gain induced by early exposure to a high-fat diet 3 weeks after weaning (6 weeks of age). This reduced weight gain was associated with decreased adiposity and increased energy expenditure and locomotor activity as the animals aged. Despite the absence of ghrelin, these Ghrl−/− mice showed a paradoxical preservation of the GH/IGF-1 axis, similar to that reported in lean compared with obese humans. These findings suggest an important role for endogenous ghrelin in the metabolic adaptation to nutrient availability.

Authors

Katherine E. Wortley, Juan-Pablo del Rincon, Jane D. Murray, Karen Garcia, Keiji Iida, Michael O. Thorner, Mark W. Sleeman

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Differential effects of diet on body weight and body composition in male...
Differential effects of diet on body weight and body composition in male Ghrl–/– mice. (A) Body weights of male Ghrl+/+ and Ghrl–/– mice maintained on standard (Std) diet were similar at 16 and 24 weeks of age (n = 8/genotype). When maintained on the HFD from 3 weeks after weaning, male Ghrl–/– mice showed a significant reduction in body weight compared with Ghrl+/+ mice at 16 and 24 weeks of age (**P < 0.05; n = 8/genotype). (B) Male Ghrl–/– mice fed the HFD 3 weeks after weaning showed a significant reduction in body weight from 13 weeks of age onward; repeated measures ANOVA, effect of age × genotype: F(1, 17) = 5.895; P < 0.0001 (*P < 0.05, post-hoc test). (C) Body composition of male Ghrl+/+ and Ghrl–/– mice at 20 weeks of age on the standard diet was similar (n = 8/genotype), whereas on the HFD, lean and fat mass were reduced in Ghrl–/– mice (**P < 0.05 for fat mass; †P < 0.01 for lean mass; n = 8/genotype). (D) Absolute food intake of male Ghrl+/+ and Ghrl–/– mice on the standard diet (n = 4–5/genotype) and HFD (n = 8/genotype) were similar during the light and dark periods. (E) Feed efficiency (calculated from caloric intake and body weight gain between 15 and 16 weeks of age) of Ghrl+/+ and Ghrl–/– mice on the HFD (n = 7/genotype).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts